Back to top
more

Lannett Co Inc (LCI)

(Delayed Data from NYSE)

$8.54 USD

8.54
1,487,457

+0.70 (8.93%)

Updated May 3, 2019 04:00 PM ET

After-Market: $8.54 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Lannett (LCI) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Lannett (LCI) delivered earnings and revenue surprises of 26.47% and 19.98%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Lannett (LCI) Q2 Earnings Expected to Decline

by Zacks Equity Research

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are Options Traders Betting on a Big Move in Lannett (LCI) Stock?

by Zacks Equity Research

Investors need to pay close attention to Lannett (LCI) stock based on the movements in the options market lately.

Is Lannett (LCI) a Great Stock for Value Investors?

by Zacks Equity Research

Let's see if Lannett (LCI) stock is a good choice for value-oriented investors right now from multiple angles.

Lannett (LCI) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Lannett (LCI) delivered earnings and revenue surprises of 10.00% and 5.86%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Lannett (LCI) Q1 Earnings Preview: What's in the Cards?

by Zacks Equity Research

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Lannett (LCI) Could Be Positioned for a Slump

by Zacks Equity Research

Lannett (LCI) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

    Lannett (LCI) Matches Q4 Earnings Estimates

    by Zacks Equity Research

    Lannett (LCI) delivered earnings and revenue surprises of 0.00% and -0.40%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

      Options Traders Expect Huge Moves in Lannett (LCI) Stock

      by Zacks Equity Research

      Lannett (LCI) needs investors to pay close attention to the stock based on moves in the options market lately.

        Lannett Set to Lose Distribution Agreement With Key Supplier

        by Zacks Equity Research

        Lannett Company's (LCI) distribution agreement with key supplier, Jerome Stevens Pharmaceuticals, not to be renewed on expiry. Shares plunge.

          Options Traders Expect Huge Moves in Lannett (LCI) Stock

          by Zacks Equity Research

          Investors need to pay close attention to Lannett (LCI) stock based on the movements in the options market lately.

            Zacks Value Investor Highlights: Lannett, Emerge Energy, Roadrunner, GameStop and Micron

            by Zacks Equity Research

            Zacks Value Investor Highlights: Lannett, Emerge Energy, Roadrunner, GameStop and Micron

              Tracey Ryniec headshot

              Should You Buy Stocks with P/Es under 5?

              by Tracey Ryniec

              Stocks with super low P/Es may seems like values, but investors should be cautious.

                Is Lannett Company (LCI) a Great Stock for Value Investors?

                by Zacks Equity Research

                Is Lannett Company (LCI) a great pick from the value investor's perspective right now? Read on to know more.

                  Lannett (LCI) Q4 Earnings In Line, Stock Up on Solid View

                  by Zacks Equity Research

                  Lannett (LCI) reported in-line Q4 earnings and sales. The FDA approved multiple pending ANDAs during the quarter. Also, the company provided strong outlook for 2018.

                    Arpita Dutt headshot

                    Generic Drug Stocks Take a Hit: Here's Why

                    by Arpita Dutt

                    As generic drug pricing concerns loom large, Teva (TEVA) and other players in the generic market saw their shares tumble last week.

                      Take a Look at 5 Stocks with Attractive Price-to-Book Ratio

                      by Zacks Equity Research

                      When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool for identifying low-priced stocks that have high-growth prospects.

                        Zacks.com featured highlights: Vishay Intertechnology, Big Lots, Applied Materials and Lannett Company

                        by Zacks Equity Research

                        Zacks.com featured highlights: Vishay Intertechnology, Big Lots, Applied Materials and Lannett Company

                          4 Low Price-to-Cash-Flow Stocks for Assured Returns

                          by Zacks Equity Research

                          There are different valuation metrics to determine a stock's inherent strength but a random selection of ratios cannot serve your purpose.

                            Arpita Dutt headshot

                            Generic Drugmakers Tumble as Perrigo Discloses DoJ Search

                            by Arpita Dutt

                            With Perrigo (PRGO) disclosing that DoJ search warrants were executed at its corporate offices, industry-wide pricing practices are back in focus.

                              Is Lannett (LCI) a Great Stock for Value Investors?

                              by Zacks Equity Research

                              Lannett (LCI) seems to be a Great Stock for Value Investors on the back of its solid key value statistics.

                                The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems

                                by Zacks Equity Research

                                The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems

                                  Will Lannett (LCI) Continue to Surge Higher?

                                  by Zacks Equity Research

                                  As of late, it has definitely been a great time to be an investor in Lannett Company, Inc. (LCI)

                                    Express Scripts (ESRX) Q4 Earnings: What's in the Cards?

                                    by Zacks Equity Research

                                    Express Scripts Holding Company (ESRX), is scheduled to report fourth-quarter 2016 results on Feb 14 after market closes.

                                      Will Q4 Earnings Hold a Surprise for DaVita (DVA) Stock?

                                      by Zacks Equity Research

                                      DaVita HealthCare Partners Inc. (DVA) is set to report fourth-quarter 2016 results after market close on Feb 9.